- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.12.24 | FDA rejects J&J's subcutaneous Rybrevant filing and AstraZeneca's full approval bid for Andexxa | ||
| 16.12.24 | Novo Holdings set to close $16.5B Catalent buy in 'coming days' after deal clears antitrust hurdles | ||
| 16.12.24 | Neurocrine's Crenessity ends 70-year drought with FDA nod for rare genetic disease | ||
| 16.12.24 | Checkpoint Therapeutics takes on Merck's mighty Keytruda with FDA approval for Unloxcyt in skin cancer | ||
| 16.12.24 | Novo Nordisk blueprints $1.2B rare disease production plant in Denmark, where it plans to hire on 400 new staffers | ||
| 16.12.24 | Bavarian Nordic inks mpox vaccine pact with Serum Institute of India, expands global reach of the shot | ||
| 16.12.24 | FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio | ||
| 13.12.24 | McKinsey agrees to $650M DOJ settlement over opioid consulting relationship with Purdue Pharma | ||
| 13.12.24 | EMA backs Merck's Welireg, Bayer's ATTR med and Gilead's liver drug from $4.3B deal | ||
| 13.12.24 | Avalere promotes Amar Urhekar, the architect of its new model, to CEO | ||
| 13.12.24 | Novo Nordisk's chief scientific officer looks to the future of GLP-1s | ||
| 13.12.24 | After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed | ||
| 12.12.24 | ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases | ||
| 12.12.24 | Corcept shows how excess cortisol might be pulling the strings in Cushing syndrome awareness campaign | ||
| 12.12.24 | After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale | ||
| 12.12.24 | CRO Ora showcases key role music plays in the blind community | ||
| 12.12.24 | Lonza plans to shed capsules business, simplify operating structure in push to become 'pure-play' CDMO | ||
| 12.12.24 | Siga's smallpox antiviral Tpoxx misses the mark in another mpox study | ||
| 12.12.24 | SABCS: Under siege from competitors, Pfizer's Ibrance scores in double-positive breast cancer | ||
| 12.12.24 | Ex-NFL stars 'Gear Up' with CDC for colorectal cancer screening push | ||
| 11.12.24 | Trump names Andrew Ferguson as pick for FTC chair in potential win for biopharma dealmaking | ||
| 11.12.24 | With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033 | ||
| 11.12.24 | Lilly CEO Ricks provides hints on how Trump will approach healthcare issues | ||
| 11.12.24 | Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing | ||
| 11.12.24 | Daiichi Sankyo builds $152M ADC plant in China as Enhertu wins national coverage |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
